US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 0.7220
  • +0.0020+0.28%
Trading Jul 29 15:09 ET
12.71MMarket Cap-1388P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-31.75%1.72M
-16.19%8.83M
-34.27%1.91M
-14.18%2.07M
-15.75%2.33M
2.76%2.53M
15.44%10.54M
8.50%2.91M
-2.10%2.41M
32.07%2.76M
Selling and administrative expenses
-13.12%757.28K
9.70%3.23M
8.73%876.4K
11.01%749.47K
7.10%733.5K
11.86%871.68K
11.82%2.95M
15.40%806.03K
6.87%675.12K
11.19%684.88K
-General and administrative expense
-13.12%757.28K
9.70%3.23M
8.73%876.4K
11.01%749.47K
7.10%733.5K
11.86%871.68K
11.82%2.95M
15.40%806.03K
6.87%675.12K
11.19%684.88K
Research and development costs
-41.57%966.11K
-26.23%5.6M
-50.76%1.04M
-24.00%1.32M
-23.27%1.59M
-1.46%1.65M
16.92%7.59M
6.07%2.1M
-5.20%1.73M
40.78%2.08M
Operating profit
31.75%-1.72M
16.19%-8.83M
34.27%-1.91M
14.18%-2.07M
15.75%-2.33M
-2.76%-2.53M
-15.44%-10.54M
-8.50%-2.91M
2.10%-2.41M
-32.07%-2.76M
Net non-operating interest income expense
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
1,358.30%112.26K
30,647.72%128.22K
19,401.72%90.49K
-11.59%21.24K
2,311.43%12.66K
1,234.14%7.7K
-96.59%417
Non-operating interest income
-9.20%82.17K
1,920.05%429.04K
674.67%98.07K
1,358.30%112.26K
30,647.72%128.22K
19,401.72%90.49K
-11.59%21.24K
2,311.43%12.66K
1,234.14%7.7K
-96.59%417
Other net income (expense)
Income before tax
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
2.39%-2.4M
-32.82%-2.76M
Income tax
Net income
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
2.39%-2.4M
-32.82%-2.76M
Net income continuous Operations
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
2.39%-2.4M
-32.82%-2.76M
Minority interest income
Net income attributable to the parent company
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
2.39%-2.4M
-32.82%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.59%-1.64M
20.10%-8.4M
37.37%-1.81M
18.58%-1.95M
20.37%-2.2M
0.90%-2.43M
-15.52%-10.52M
-8.05%-2.9M
2.39%-2.4M
-32.82%-2.76M
Basic earnings per share
47.37%-0.1
26.51%-0.61
47.83%-0.12
26.32%-0.14
27.27%-0.16
0.00%-0.19
-13.70%-0.83
-9.52%-0.23
5.00%-0.19
-29.41%-0.22
Diluted earnings per share
47.37%-0.1
26.51%-0.61
47.83%-0.12
26.32%-0.14
27.27%-0.16
0.00%-0.19
-13.70%-0.83
-9.52%-0.23
5.00%-0.19
-29.41%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -31.75%1.72M-16.19%8.83M-34.27%1.91M-14.18%2.07M-15.75%2.33M2.76%2.53M15.44%10.54M8.50%2.91M-2.10%2.41M32.07%2.76M
Selling and administrative expenses -13.12%757.28K9.70%3.23M8.73%876.4K11.01%749.47K7.10%733.5K11.86%871.68K11.82%2.95M15.40%806.03K6.87%675.12K11.19%684.88K
-General and administrative expense -13.12%757.28K9.70%3.23M8.73%876.4K11.01%749.47K7.10%733.5K11.86%871.68K11.82%2.95M15.40%806.03K6.87%675.12K11.19%684.88K
Research and development costs -41.57%966.11K-26.23%5.6M-50.76%1.04M-24.00%1.32M-23.27%1.59M-1.46%1.65M16.92%7.59M6.07%2.1M-5.20%1.73M40.78%2.08M
Operating profit 31.75%-1.72M16.19%-8.83M34.27%-1.91M14.18%-2.07M15.75%-2.33M-2.76%-2.53M-15.44%-10.54M-8.50%-2.91M2.10%-2.41M-32.07%-2.76M
Net non-operating interest income expense -9.20%82.17K1,920.05%429.04K674.67%98.07K1,358.30%112.26K30,647.72%128.22K19,401.72%90.49K-11.59%21.24K2,311.43%12.66K1,234.14%7.7K-96.59%417
Non-operating interest income -9.20%82.17K1,920.05%429.04K674.67%98.07K1,358.30%112.26K30,647.72%128.22K19,401.72%90.49K-11.59%21.24K2,311.43%12.66K1,234.14%7.7K-96.59%417
Other net income (expense)
Income before tax 32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M2.39%-2.4M-32.82%-2.76M
Income tax
Net income 32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M2.39%-2.4M-32.82%-2.76M
Net income continuous Operations 32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M2.39%-2.4M-32.82%-2.76M
Minority interest income
Net income attributable to the parent company 32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M2.39%-2.4M-32.82%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.59%-1.64M20.10%-8.4M37.37%-1.81M18.58%-1.95M20.37%-2.2M0.90%-2.43M-15.52%-10.52M-8.05%-2.9M2.39%-2.4M-32.82%-2.76M
Basic earnings per share 47.37%-0.126.51%-0.6147.83%-0.1226.32%-0.1427.27%-0.160.00%-0.19-13.70%-0.83-9.52%-0.235.00%-0.19-29.41%-0.22
Diluted earnings per share 47.37%-0.126.51%-0.6147.83%-0.1226.32%-0.1427.27%-0.160.00%-0.19-13.70%-0.83-9.52%-0.235.00%-0.19-29.41%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg